Pott, C., Brixius, K., Bundkirchen, A., Bölck, B., Bloch, W., Steinritz, D., . . . Schwinger, R. H. G. (2003). The preferential β(3)-adrenoceptor agonist BRL 37344 increases force via β(1)-/β(2)-adrenoceptors and induces endothelial nitric oxide synthase via β(3)-adrenoceptors in human atrial myocardium.

Pott, C., K. Brixius, A. Bundkirchen, B. Bölck, W. Bloch, D. Steinritz, U. Mehlhorn, i R H G. Schwinger. The Preferential β(3)-adrenoceptor Agonist BRL 37344 Increases Force Via β(1)-/β(2)-adrenoceptors and Induces Endothelial Nitric Oxide Synthase Via β(3)-adrenoceptors in Human Atrial Myocardium. 2003.

Pott, C., et al. The Preferential β(3)-adrenoceptor Agonist BRL 37344 Increases Force Via β(1)-/β(2)-adrenoceptors and Induces Endothelial Nitric Oxide Synthase Via β(3)-adrenoceptors in Human Atrial Myocardium. 2003.